Reappraising screening metrics and methodological considerations in artificial intelligence-augmented mammography

The Lancet: Digital Health · Published 2026-02-01 · DOI 10.1016/j.landig.2026.100996

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.landig.2026.100996

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Navigating the promise and pitfalls of dashboards in health policy decision making: experiences from Ghana, India, and South Africa · The Lancet: Digital Health · 2026 · Same journal
• Deep learning model for pathological invasiveness prediction using smartphone-based surgical resection images in clinical stage IA lung adenocarcinoma (SuRImage): a prospective, multicentric, diagnostic study · The Lancet: Digital Health · 2026 · Same journal
• Virtual reality-based cognitive remediation versus virtual reality control in people with mood or psychosis spectrum disorders in Denmark: a single-centre, double-blind, randomised controlled trial · The Lancet: Digital Health · 2026 · Same journal
• RareArena: a comprehensive benchmark dataset unveiling the potential of large language models in rare disease diagnosis · The Lancet: Digital Health · 2026 · Same journal
• Ischaemic stroke recurrence in patients with symptomatic intracranial atherosclerotic stenosis in China (PROMISE): a multivariable prediction model development and validation study · The Lancet: Digital Health · 2026 · Same journal
• Effects of the COVID-19 pandemic on antibiotic use and resistance in French hospitals, 2019–22: a retrospective ecological analysis of national surveillance data · The Lancet: Digital Health · 2026 · Same journal
• Development of a target product profile for artificial intelligence in diabetic eye screening in England: a modified Delphi consensus study · The Lancet: Digital Health · 2026 · Same journal
• Predicting the risk of serious muscle disorders in individuals eligible for statin treatment in England: derivation and validation of a clinical prediction model · The Lancet: Digital Health · 2026 · Same journal
• Artificial intelligence for post-treatment prediction in age-related macular degeneration · The Lancet: Digital Health · 2026 · Same journal
• Trust, not technology: governing access to health data as the decisive challenge for the UK · The Lancet: Digital Health · 2026 · Same journal